Clinical trial
Method Comparison/User Evaluation of the i-SENS Self-Monitoring Blood Glucose / β-Ketone System (CareSens PRO GK BT)
NCT05833100 is registered in ClinicalTrials.gov with i-SENS, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Method Comparison/User Evaluation of the i-SENS Self-Monitoring Blood Glucose / β-Ketone System (CareSens PRO GK BT)
- Lead sponsor
- i-SENS, Inc.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- August 15, 2022
- Completion date
- February 23, 2023
- Enrollment
- 76 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes